drugset / Trial / NCT00343980
Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Asia, Europe and Oceania. The aim of this research study is to compare the efficacy of adding inhaled preprandial insulin to glimepiride compared to adding rosiglitazone to glimepiride for the treatment of type 2 diabetes and to verify its safety (hypoglycaemia, pulmonary function, body weight, insulin antibodies and side effects)
Timeline
- Start
- 2006-10-10
- Primary completion
- 2008-03-10
- Completion
- 2008-03-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rosiglitazone | Small molecule | 4 mg | Oral |
| Subject | inhaled human insulin | Unknown | — | Inhaled |
| Background | Glimepiride | Small molecule | 4 mg | Oral |